Literature DB >> 11435305

Increased thrombogenesis and embolus formation in mice lacking glycoprotein V.

H Ni1, V Ramakrishnan, Z M Ruggeri, J M Papalia, D R Phillips, D D Wagner.   

Abstract

The glycoprotein (GP) Ib-V-IX complex plays a critical role in initiating platelet adhesion to von Willebrand factor (vWF) at the site of vascular injury. The complex also forms a high-affinity binding site for thrombin. Using an intravital microscopy mouse model, it was previously established that vWF plays a critical role in mediating platelet adhesion and thrombus formation following mesenteric arteriolar injury induced by ferric chloride. Further characterization of this model showed that these thrombotic events were also thrombin dependent. Using this vWF- and thrombin-dependent model, this study shows that GP V gene deficiency significantly accelerates both platelet adhesion and thrombus formation in mice following arteriolar injury. The time required for vessel occlusion in GP V-deficient (GP V(-/-)) mice was significantly shorter than that in wild-type mice. Interestingly, large emboli were also produced in GP V(-/-) mice, but not in wild-type mice, causing frequent downstream occlusion. However, when the 2 genotypes were compared in the in vitro perfusion chamber where thrombin was inhibited by heparin, no significant differences were found in either initial single-platelet adhesion or thrombus volume. These results demonstrate that GP V(-/-) mice have accelerated thrombus growth in response to vascular injury and suggest that this is caused by enhanced thrombin-induced platelet activation rather than enhanced binding of GPIb-V-IX to vWF. Absence of GP V also compromises thrombus stability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435305     DOI: 10.1182/blood.v98.2.368

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis.

Authors:  Sassan HajMohammadi; Keiichi Enjyoji; Marc Princivalle; Patricia Christi; Miroslav Lech; David Beeler; Helen Rayburn; John J Schwartz; Samad Barzegar; Ariane I de Agostini; Mark J Post; Robert D Rosenberg; Nicholas W Shworak
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Activation-independent platelet adhesion and aggregation under elevated shear stress.

Authors:  Zaverio M Ruggeri; Jennifer N Orje; Rolf Habermann; Augusto B Federici; Armin J Reininger
Journal:  Blood       Date:  2006-06-13       Impact factor: 22.113

3.  Plasma fibronectin supports hemostasis and regulates thrombosis.

Authors:  Yiming Wang; Adili Reheman; Christopher M Spring; Jalil Kalantari; Alexandra H Marshall; Alisa S Wolberg; Peter L Gross; Jeffrey I Weitz; Margaret L Rand; Deane F Mosher; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

4.  Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Authors:  Christian Kannemeier; Aya Shibamiya; Fumie Nakazawa; Heidi Trusheim; Clemens Ruppert; Philipp Markart; Yutong Song; Eleni Tzima; Elisabeth Kennerknecht; Michael Niepmann; Marie-Luise von Bruehl; Daniel Sedding; Steffen Massberg; Andreas Günther; Bernd Engelmann; Klaus T Preissner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

5.  The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.

Authors:  Yacine Boulaftali; Lamia Lamrani; Marie-Catherine Rouzaud; Stéphane Loyau; Martine Jandrot-Perrus; Marie-Christine Bouton; Benoît Ho-Tin-Noé
Journal:  Thromb Haemost       Date:  2012-03-08       Impact factor: 5.249

6.  Plasma fibronectin promotes thrombus growth and stability in injured arterioles.

Authors:  Heyu Ni; Peter S T Yuen; Jessie M Papalia; Jane E Trevithick; Takao Sakai; Reinhard Fässler; Richard O Hynes; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

Review 7.  Platelet receptors and signaling in the dynamics of thrombus formation.

Authors:  José Rivera; María Luisa Lozano; Leyre Navarro-Núñez; Vicente Vicente
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

8.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.

Authors:  Patrick Andre; Suzanne M Delaney; Thomas LaRocca; Diana Vincent; Francis DeGuzman; Marzena Jurek; Beverley Koller; David R Phillips; Pamela B Conley
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 9.  Future innovations in anti-platelet therapies.

Authors:  N E Barrett; L Holbrook; S Jones; W J Kaiser; L A Moraes; R Rana; T Sage; R G Stanley; K L Tucker; B Wright; J M Gibbins
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.

Authors:  Benjamin Xiaoyi Li; Xiangrong Dai; Xiaohong Ruby Xu; Reheman Adili; Miguel Antonio Dias Neves; Xi Lei; Chuanbin Shen; Guangheng Zhu; Yiming Wang; Hui Zhou; Yan Hou; Tiffany Ni; Yfke Pasman; Zhongqiang Yang; Fang Qian; Yanan Zhao; Yongxiang Gao; Jing Liu; Maikun Teng; Alexandra H Marshall; Eric G Cerenzia; Mandy Lokyee Li; Heyu Ni
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.